ASTRO issues guide on radiation therapy for glioma
The American Society for Radiation Oncology (ASTRO) has issued a guide on th...Read more on AuntMinnie.comRelated Reading:
ASTRO recognizes fellows class for 2022
ASTRO sees opportunity in CMS delay of RO Model
AUA, ASTRO release new prostate cancer guideline
ASTRO releases EBRT guidelines for liver cancer treatment
ASTRO 2021 studies tackle racial disparities, high costs (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 31, 2022 Category: Radiology Source Type: news
Consumer Health: Treating glioblastoma
Glioblastoma Awareness Day will be observed Wednesday, July 20, which makes this a good time to learn more about treating one of the most complex, deadly and treatment-resistant cancers. More than 13,400 people in the U.S. will be diagnosed with glioblastoma in 2022, according to the National Brain Tumor Society. The five-year survival rate is 6.8%, and the median length of survival is eight months. Glioblastoma, also known as glioblastoma multiforme, is a type of glioma,… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 18, 2022 Category: Databases & Libraries Source Type: news
Can Star Trek-like technology improve patient access to imaging?
Functioning like the legendary “tricorder” on Star Trek, a smartphone coul...Read more on AuntMinnie.comRelated Reading:
Machine learning, radiomics differentiates glioma
Video from SIIM 2022: Amy Thompson on trends in imaging IT
SIIM: Neck pain in the radiology reading room? Consider the 'Han Solo' approach
SIIM: AI can help simplify radiology reports for patients
HIMSS: NIH finds favor with multimedia radiology reports (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 1, 2022 Category: Radiology Source Type: news
Oncolytic Virus Infusion Promising as Brain-Stem Glioma Treatment
(MedPage Today) -- Intratumoral infusion of an oncolytic virus offered safe and feasible results, along with encouraging efficacy, in pediatric patients with diffuse intrinsic pontine glioma (DIPG), researchers reported.
In the phase I study of... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 29, 2022 Category: Hematology Source Type: news
Machine learning, radiomics differentiates glioma
An automated method based on a machine-learning algorithm and MRI radiomic...Read more on AuntMinnie.comRelated Reading:
SIIM: Neck pain in the radiology reading room? Consider the 'Han Solo' approach
SIIM: AI can detect multiple myeloma lesions on whole-body CT
Deep learning classifies brain tumors on single MRI scans
MRI, histopathologic features boost glioma survival prediction accuracy
AI can identify sarcopenia in glioblastoma patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 28, 2022 Category: Radiology Source Type: news
Janssen Presents Initial Results from the Phase 2 RAGNAR Study of BALVERSA ® (erdafitinib) in Patients with Advanced Solid Tumors with FGFR Alterations
CHICAGO, ILLINOIS, June 7, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced initial results from the pivotal Phase 2 RAGNAR study evaluating the investigational use of BALVERSA® (erdafitinib), a fibroblast growth factor receptor (FGFR) kinase inhibitor, in patients with advanced solid tumors with prespecified FGFR alterations. At a planned interim analysis (IA), responses were observed across a variety of FGFR-driven solid tumors for patients who had exhausted standard treatment options prior to being treated with BALVERSA®.[1] These results will be featured in an oral presentation (...
Source: Johnson and Johnson - June 7, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Targeted Combo Topples Chemo in Pediatric Glioma With BRAF Mutations
(MedPage Today) -- CHICAGO -- Dual targeted therapy with a BRAF and MEK inhibitor quadrupled responses in pediatric BRAF-mutant low-grade glioma and reduced risk of disease progression or death compared with standard chemotherapy, a phase II... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 6, 2022 Category: Hematology Source Type: news
Targeted Therapy an'Important Advance' in Childhood Glioma Targeted Therapy an'Important Advance' in Childhood Glioma
Combining dabrafenib with trametinib markedly improved response rates and delayed progression over standard-of-care chemotherapy in pediatric BRAF V600-mutant low-grade glioma in a phase 2 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 6, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Imaging Biometrics seeks FDA clearance for IB Zero G
Advanced visualization software developer Imaging Biometrics has submitted ...Read more on AuntMinnie.comRelated Reading:
Imaging Biometrics highlights findings on MRI-based glioma monitoring
Imaging Biometrics lands software install at Ala. medical center
Imaging Biometrics secures patent for zero-dose imaging software
Imaging Biometrics wins USC installation
Imaging Biometrics added to Arterys marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 31, 2022 Category: Radiology Source Type: news
The Potential of Nanopore Sequencing Technology in Cancer Diagnosis
In this webinar, Mashiat Mimosa will discuss the potential of a new sequencing method that detects glioma tumors in brain tissue. (Source: The Scientist)
Source: The Scientist - May 11, 2022 Category: Science Tags: Sponsored Webinars Source Type: news
Blood Biomarkers May Help ID Primary CNS Lymphoma, High - Grade Glioma
Systemic inflammatory biomarkers may be useful in the differential diagnosis of primary central nervous system lymphoma, high - grade glioma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 18, 2022 Category: Cancer & Oncology Tags: Neurology, Oncology, Pathology, Journal, Source Type: news
Blood Biomarkers May Help ID Primary CNS Lymphoma, High-Grade Glioma
MONDAY, April 18, 2022 -- Systemic inflammatory biomarkers may aid in differentiating primary central nervous system lymphoma (PCNSL) from high-grade glioma (HGG), according to a study published online April 4 in CNS Oncology.
Tejpal Gupta, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2022 Category: Pharmaceuticals Source Type: news
Assay-Guided Chemo in Recurrent Glioma Linked to Longer Survival Assay-Guided Chemo in Recurrent Glioma Linked to Longer Survival
A new assay can help guide chemotherapy treatments for recurrent high-grade gliomas.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Imaging Biometrics highlights findings on MRI-based glioma monitoring
Advanced visualization software firm Imaging Biometrics is highlighting researc...Read more on AuntMinnie.comRelated Reading:
Imaging Biometrics lands software install at Ala. medical center
Imaging Biometrics secures patent for zero-dose imaging software
IB, Mayo Clinic partner to track brain lesions
Imaging Biometrics wins USC installation
Imaging Biometrics added to Arterys marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 7, 2022 Category: Radiology Source Type: news
What Is the Survival Rate of Glioma?
Title: What Is the Survival Rate of Glioma?Category: Diseases and ConditionsCreated: 2/16/2022 12:00:00 AMLast Editorial Review: 2/16/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 16, 2022 Category: Cancer & Oncology Source Type: news
